Biotechnology

PACE panel notes challenges IRA poses for patients

Changes brought on by the Inflation Reduction Act (IRA) often increase patient c...

Alamar, Nightingale Health Team up on UK Biobank Neurod...

Nightingale Health will run the measurements in its labs using Alamar’s NULISA p...

Recursion Eyes H2 2027 Pivotal Trial for Lead Candidate...

Following 12 weeks of treatment, Recursion said, 87% of patients (13 of 15) had ...

Precision Automation Meets Biology

In this GEN podcast, a cellular workflow automation specialist from Molecular De...

Lost and Found: Neural Pathway for Forgetting Found in ...

Researchers identified the key molecular and neural pathways that cause the nema...

PACE panel lays out patient input possibilities in PDUF...

The law guiding U.S. drug approval was created to meet the demands of patient ad...

Inflammatory Process Identified as Link Between Pulmona...

A study investigating the observed connection between pulmonary hypertension and...

FDA Sets May 1 PDUFA Action Date for uniQure’s Huntingt...

uniQure has aligned with the FDA on what the company calls key elements of the c...

FDA Delays PDUFA Action on Agios’ Mitapivat sNDA for SCD

The FDA has delayed a decision on Agios Pharmaceuticals’ supplemental New Drug A...

Sentira Brings Claude’s AI to 10x Genomics’ Chromium Pl...

10x Genomics launches Sentira, an Anthropic Claude-powered AI platform designed ...

StockWatch: Gene Editing Shares Jump on ESGCT Data, FDA...

Shares of gene editing therapy companies mostly surged this past week on two gro...

100 Million-Cell AI-Ready Dataset with Single-Cell and ...

Parse Biosciences and Nomic Bio are partnering to create Cascade, a 100-million-...

Opentrons Raises $40M in Series E to Expand Its Robotic...

According to the company, the funds will support the next phase of its growth in...

No Nonsense: David Liu Lauds Progress in Disease-Agnost...

Liu ensured that his return visit to ESGCT (having spoken at the congress in Bar...

Blocking Protein Slows Pancreatic Tumor Growth and Redu...

Scientists identified a potential therapeutic target for pancreatic ductal cell ...

Eating disorders are on the rise. GLP-1s could make thi...

GLP-1 weight-loss drugs are one of the biggest biotech breakthroughs of the last...